C4 Therapeutics, Inc. earnings per share and revenue

CCCC earnings per share for the last quarter are -0.35 USD whereas the estimation was -0.38 USD which accounts for 7.64% surprise. Company revenue for the same period amounts to 15.40 M USD despite the estimated figure of 5.90 M USD. Estimated earnings per share for the next quarter are -0.49 USD, and revenue is expected to reach 5.11 M USD. Also watch annual changes over time to get a bigger picture of CCCC earnings per share and revenue dynamics.